These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17348638)

  • 21. Piperazine-2,3-dicarboxylic acid derivatives as dual antagonists of NMDA and GluK1-containing kainate receptors.
    Irvine MW; Costa BM; Dlaboga D; Culley GR; Hulse R; Scholefield CL; Atlason P; Fang G; Eaves R; Morley R; Mayo-Martin MB; Amici M; Bortolotto ZA; Donaldson L; Collingridge GL; Molnár E; Monaghan DT; Jane DE
    J Med Chem; 2012 Jan; 55(1):327-41. PubMed ID: 22111545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping the ligand binding sites of kainate receptors: molecular determinants of subunit-selective binding of the antagonist [3H]UBP310.
    Atlason PT; Scholefield CL; Eaves RJ; Mayo-Martin MB; Jane DE; Molnár E
    Mol Pharmacol; 2010 Dec; 78(6):1036-45. PubMed ID: 20837679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solid-phase synthesis of polyamine toxin analogues: potent and selective antagonists of Ca2+-permeable AMPA receptors.
    Kromann H; Krikstolaityte S; Andersen AJ; Andersen K; Krogsgaard-Larsen P; Jaroszewski JW; Egebjerg J; Strømgaard K
    J Med Chem; 2002 Dec; 45(26):5745-54. PubMed ID: 12477358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structures of the kainate receptor GluR5 ligand binding core dimer with novel GluR5-selective antagonists.
    Mayer ML; Ghosal A; Dolman NP; Jane DE
    J Neurosci; 2006 Mar; 26(11):2852-61. PubMed ID: 16540562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contributions of different kainate receptor subunits to the properties of recombinant homomeric and heteromeric receptors.
    Fisher MT; Fisher JL
    Neuroscience; 2014 Oct; 278():70-80. PubMed ID: 25139762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Agonist binding to the GluK5 subunit is sufficient for functional surface expression of heteromeric GluK2/GluK5 kainate receptors.
    Fisher JL; Housley PR
    Cell Mol Neurobiol; 2013 Nov; 33(8):1099-108. PubMed ID: 23975096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure and Affinity of Two Bicyclic Glutamate Analogues at AMPA and Kainate Receptors.
    Møllerud S; Pinto A; Marconi L; Frydenvang K; Thorsen TS; Laulumaa S; Venskutonytė R; Winther S; Moral AMC; Tamborini L; Conti P; Pickering DS; Kastrup JS
    ACS Chem Neurosci; 2017 Sep; 8(9):2056-2064. PubMed ID: 28691798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, biological evaluation, and pharmacophore generation of uracil, 4(3H)-pyrimidinone, and uridine derivatives as potent and selective inhibitors of parainfluenza 1 (Sendai) virus.
    Saladino R; Crestini C; Palamara AT; Danti MC; Manetti F; Corelli F; Garaci E; Botta M
    J Med Chem; 2001 Dec; 44(26):4554-62. PubMed ID: 11741474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological activity of C10-substituted analogs of the high-affinity kainate receptor agonist dysiherbaine.
    Lash-Van Wyhe LL; Postila PA; Tsubone K; Sasaki M; Pentikäinen OT; Sakai R; Swanson GT
    Neuropharmacology; 2010 Mar; 58(3):640-9. PubMed ID: 19962997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of the new radioligand (S)-[3H]AMPA to rat brain synaptic membranes: effects of a series of structural analogues of the non-NMDA receptor agonist willardiine.
    Hawkins LM; Beaver KM; Jane DE; Taylor PM; Sunter DC; Roberts PJ
    Neuropharmacology; 1995 Apr; 34(4):405-10. PubMed ID: 7566471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological characterization of the competitive GLUK5 receptor antagonist decahydroisoquinoline LY466195 in vitro and in vivo.
    Weiss B; Alt A; Ogden AM; Gates M; Dieckman DK; Clemens-Smith A; Ho KH; Jarvie K; Rizkalla G; Wright RA; Calligaro DO; Schoepp D; Mattiuz EL; Stratford RE; Johnson B; Salhoff C; Katofiasc M; Phebus LA; Schenck K; Cohen M; Filla SA; Ornstein PL; Johnson KW; Bleakman D
    J Pharmacol Exp Ther; 2006 Aug; 318(2):772-81. PubMed ID: 16690725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential antagonism of alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid-preferring and kainate-preferring receptors by 2,3-benzodiazepines.
    Wilding TJ; Huettner JE
    Mol Pharmacol; 1995 Mar; 47(3):582-7. PubMed ID: 7700255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy.
    Löscher W; Lehmann H; Behl B; Seemann D; Teschendorf HJ; Hofmann HP; Lubisch W; Höger T; Lemaire HG; Gross G
    Eur J Neurosci; 1999 Jan; 11(1):250-62. PubMed ID: 9987029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An efficient alternative route to 3,6-disubstituted-furo[2,3-d]pyrimidin-2-one analogues.
    Janeba Z; Maklad N; Robins MJ
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1729-43. PubMed ID: 16438044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antagonist pharmacology of kainate- and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring receptors.
    Wilding TJ; Huettner JE
    Mol Pharmacol; 1996 Mar; 49(3):540-6. PubMed ID: 8643094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Block of open channels of recombinant AMPA receptors and native AMPA/kainate receptors by adamantane derivatives.
    Magazanik LG; Buldakova SL; Samoilova MV; Gmiro VE; Mellor IR; Usherwood PN
    J Physiol; 1997 Dec; 505 ( Pt 3)(Pt 3):655-63. PubMed ID: 9457643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The neurotoxin domoate causes long-lasting inhibition of the kainate receptor GluK5 subunit.
    Fisher JL
    Neuropharmacology; 2014 Oct; 85():9-17. PubMed ID: 24859608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and pharmacological characterisation of arctigenin analogues as antagonists of AMPA and kainate receptors.
    Rečnik LM; Thatcher RJ; Mallah S; Butts CP; Collingridge GL; Molnár E; Jane DE; Willis CL
    Org Biomol Chem; 2021 Nov; 19(42):9154-9162. PubMed ID: 34642722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the selective kainate receptor antagonist ACET on altered sensorimotor gating in a genetic model of reduced NMDA receptor function.
    Duncan GE; Koller BH; Moy SS
    Brain Res; 2012 Mar; 1443():98-105. PubMed ID: 22297176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of willardiine-induced currents through rat GluR6/KA-2 kainate receptor channels by Zinc and other divalent cations.
    Fukushima T; Shingai R; Ogurusu T; Ichinose M
    Neurosci Lett; 2003 Oct; 349(2):107-10. PubMed ID: 12946564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.